Continue bleeding after image-guided breast biopsies or stop? upholding antithrombotic treatment.

Published Date: 17 May 2023

A study in the American Journal of Roentgenology (AJR) found that there was no significant difference in the frequency of imaging-apparent and palpable hematoma between patients who were temporarily discontinuing treatment and those who were continuing it.

Read Full News

Latest News

Sep 18 2026 This Week in Cardiology

Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week’s podcast.

Time to REACT Earlier: Is CVD Prevention Starting Too Late?

How reassuring is a low 10-year CV risk? REACT reveals how early silent atherosclerosis begins and asks whether CVD prevention should start sooner.

Never Too Late (or Too Early) for Lipid Lowering

ESC studies on statin use in patients over 70 years and identifying subclinical atherosclerosis via 3D ultrasonography of the carotid and femoral arteries and coronary CTA are discussed.

Narrative Videos to Improve Lung Cancer Screening Uptake

Short, veteran-led clips could stem fear, anxiety associated with screening

What the 2026 ESC Guidelines Mean for Primary Care

The guideline update is a revolution that will promote evidence-based, person-centered classification and management of heart failure.

Sep 11 2026 This Week in Cardiology

A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week’s podcast.

How reassuring is a low 10-year CV risk? REACT reveals how early silent atherosclerosis begins and asks whether CVD prevention should start sooner.

ESC studies on statin use in patients over 70 years and identifying subclinical atherosclerosis via 3D ultrasonography of the carotid and femoral arteries and coronary CTA are discussed.

Short, veteran-led clips could stem fear, anxiety associated with screening

The guideline update is a revolution that will promote evidence-based, person-centered classification and management of heart failure.

A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

News All Time

HTTP error: 503

When Grief Was Called Hysteria

A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.

The Heart of the Matter

How a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.
HTTP error: 503HTTP error: 503HTTP error: 503

The Looming 100-Million Cancer Workforce Crisis

Global workforce inequities are widening the cancer survival gap. Prof David Kerr highlights the stark realities and calls for an improved training approach.

Are Smart Glasses the Future of Collaborative Surgery?

Orthopedic surgeon Amgad Nakhla is using smart glasses in theater to bring remote expertise into com-plex cases and support real-time decisions.
HTTP error: 503HTTP error: 503HTTP error: 503

Preview: New Thyroid Nodule Guidelines

Drs Kaniksha Desai and Victor Bernet discuss the new guidelines for thyroid nodules.

Migraine and Stroke: What's the Real Risk?

Neurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.
HTTP error: 503

Pancreatic Cancer Risk Much Higher for Certain Group, Study Suggests

Long-term follow-up of low-risk pancreatic cystic lesions may be necessary

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

Registry tracked incidence, prognostic impact of early hemodynamic valve deterioration

Recommended News For You

Recommended Articles For You

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot